Cited by 199Nanoparticle-Based Drug DeliveryNanotechnology research and applicationsBarrier Structure and Function Studies

Nanotechnology—novel therapeutics for CNS disorders

Open access
Srikanth, Maya, Kessler, John A.·2012·Nature Reviews Neurology

Abstract

Research into treatments for diseases of the CNS has made impressive strides in the past few decades, but therapeutic options are limited for many patients with CNS disorders. Nanotechnology has emerged as an exciting and promising new means of treating neurological disease, with the potential to fundamentally change the way we approach CNS-targeted therapeutics. Molecules can be nanoengineered to cross the blood-brain barrier, target specific cell or signalling systems, respond to endogenous stimuli, or act as vehicles for gene delivery, or as a matrix to promote axon elongation and support cell survival. The wide variety of available nanotechnologies allows the selection of a nanoscale material with the characteristics best suited to the therapeutic challenges posed by an individual CNS disorder. In this Review, we describe recent advances in the development of nanotechnology for the treatment of neurological disorders-in particular, neurodegenerative disease and malignant brain tumours-and for the promotion of neuroregeneration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2012.76

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The use of carbon-nanotube-based electrical stimulation of targets deep within the brain has been proposed as a novel treatment modality for patients with Parkinson's disease and other CNS disorders.

    “The use of carbon-nanotube-based electrical stimulation of targets deep within the brain has been proposed as a novel treatment modality for patients with Parkinson’s disease and other CNS disorders”

    From Human Brain/Cloud Interface (2019) · cites this paper as Srikanth and Kessler, 2012

    The Parkinson disease section proposes carbon-nanotube-based deep brain stimulation as a possible treatment for Parkinson disease, based on neuronal stimulation findings. It does not propose that specific method for other CNS disorders; its broader discussion concerns nanotechnology generally. Page numbers are unavailable in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 126 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Srikanth, M., & Kessler, J. A.
Affiliations
Northwestern University (US)
Corresponding author
Srikanth, Maya
Venue
Nature Reviews Neurology
Published
2012-04-24
Volume
8
Issue
6
Pages
307-318
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
OpenAlex
W2312871196
Cited by
198
References
126
Citations by year
2026: 6 · 2025: 13 · 2024: 14 · 2023: 14 · 2022: 22 · 2021: 19 · 2020: 17 · 2019: 14 · 2018: 15 · 2017: 9 · 2016: 16 · 2015: 19 · 2014: 9 · 2013: 9 · 2012: 2
FWCI
0.64
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (R01NS020778, F30NS065590, R01NS020013)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB003806)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
nanotechnology, blood-brain barrier, neurodegenerative diseases, brain tumors, nerve regeneration, gene delivery, axon guidance, stimuli-responsive nanomaterials, clinical translation
MeSH terms
Central Nervous System Diseases, Humans, Nanotechnology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review